Insider · CIK 0001361712
Stampacchia Otello
Reports to the SEC for 14 companies · SAN DIEGO, CA
Transactions
50
Companies
14
Filings
11
CIK
0001361712
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-16 | IMAImageneBio, Inc. · Stock Option (right to buy)A Award | — |
| 2025-07-25 | IMAImageneBio, Inc.M Exercise/Conversion | — |
| 2025-07-25 | IMAImageneBio, Inc.P Purchase | +$8M |
| 2025-07-25 | IMAImageneBio, Inc. · Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-06-07 | IMAImageneBio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-06-09 | IMAImageneBio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2022-06-22 | Kronos Bio, Inc.Stock Option (Right to Buy)A Award | — |
| 2022-06-09 | IMAImageneBio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-12-21 | IMAImageneBio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-06-22 | Kronos Bio, Inc.Stock Option (Right to Buy)A Award | — |
| 2021-03-30 | IMAImageneBio, Inc.C Conversion | — |
| 2021-03-30 | IMAImageneBio, Inc.A Award | +$7.2M |
| 2021-03-30 | IMAImageneBio, Inc. · Series B Preferred StockC Conversion | — |
| 2021-01-11 | Omega Alpha SPACP Purchase | +$5.01M |
| 2020-12-21 | IMAImageneBio, Inc. · Series B Preferred StockA Award | +$18M |
| 2020-10-14 | Kronos Bio, Inc.C Conversion | — |
| 2020-10-14 | Kronos Bio, Inc.C Conversion | — |
| 2020-10-14 | Kronos Bio, Inc.C Conversion | +$5.92M |
| 2020-10-14 | Kronos Bio, Inc.P Purchase | +$8.55M |
| 2020-10-14 | Kronos Bio, Inc.Series Seed Preferred StockC Conversion | — |
| 2020-10-14 | Kronos Bio, Inc.Series A Preferred StockC Conversion | — |
| 2020-10-14 | Kronos Bio, Inc.Convertible Promissory NoteC Conversion | — |
| 2020-06-18 | Morphic Holding, Inc.Director Stock Option (right to buy)A Award | — |
| 2019-07-01 | Morphic Holding, Inc.C Conversion | — |
| 2019-07-01 | Morphic Holding, Inc.C Conversion | — |
| 2019-07-01 | Morphic Holding, Inc.P Purchase | +$2M |
| 2019-07-01 | Morphic Holding, Inc.Series A Preferred StockC Conversion | — |
| 2019-07-01 | Morphic Holding, Inc.Series B Preferred StockC Conversion | — |
| 2019-06-10 | GOSSGossamer Bio, Inc. · Stock Option (right to buy)A Award | — |
| 2010-03-04 | MICROMET, INC.S Sale | −$442K |
| 2010-03-03 | MICROMET, INC.S Sale | −$884K |
| 2010-03-02 | MICROMET, INC.S Sale | −$418K |
| 2010-02-19 | MICROMET, INC.S Sale | −$16K |
| 2010-02-18 | MICROMET, INC.S Sale | −$201K |
| 2010-02-17 | MICROMET, INC.S Sale | −$88K |
| 2010-02-16 | MICROMET, INC.S Sale | −$64.4K |
| 2010-02-12 | MICROMET, INC.S Sale | −$521K |
| 2010-02-11 | MICROMET, INC.S Sale | −$955K |
| 2010-02-10 | MICROMET, INC.S Sale | −$651K |
| 2010-02-09 | MICROMET, INC.S Sale | −$856K |
| 2010-02-08 | MICROMET, INC.S Sale | −$1.09M |
| 2010-02-05 | MICROMET, INC.S Sale | −$182K |
| 2010-02-04 | MICROMET, INC.S Sale | −$485K |
| 2010-02-03 | MICROMET, INC.S Sale | −$527K |
| 2010-02-02 | MICROMET, INC.S Sale | −$1.18M |
| 2010-02-01 | MICROMET, INC.S Sale | −$807K |
| 2010-01-28 | MICROMET, INC.S Sale | −$120K |
| 2010-01-27 | MICROMET, INC.S Sale | −$304K |
| 2010-01-26 | MICROMET, INC.S Sale | −$1.33M |
| 2010-01-25 | MICROMET, INC.S Sale | −$2.71M |
Recent filings
- 4Stampacchia Otello0001361712-26-000002SEC(opens sec.gov)
- 4Stampacchia Otello0001415889-25-020598SEC(opens sec.gov)
- 4Stampacchia Otello0000950170-24-071305SEC(opens sec.gov)
- 4Stampacchia Otello0000899243-23-015446SEC(opens sec.gov)
- 4Stampacchia Otello0001209191-22-039782SEC(opens sec.gov)
- 4Stampacchia Otello0000899243-22-022256SEC(opens sec.gov)
- 4Stampacchia Otello0000899243-21-049694SEC(opens sec.gov)
- 4Stampacchia Otello0001209191-21-042885SEC(opens sec.gov)
- 4Stampacchia Otello0000899243-21-014390SEC(opens sec.gov)
- 4Stampacchia Otello0001104659-21-003866SEC(opens sec.gov)
- 4Stampacchia Otello0001209191-20-055045SEC(opens sec.gov)
Companies
- Gossamer Bio, Inc.10% Owner, Former director.GOSS
- ImageneBio, Inc.DirectorIMA
- IMMUNIC, INC.10% OwnerIMUX
- Kezar Life Sciences, Inc.Former 10% OwnerKZR
- Kronos Bio, Inc.Director
- Lexeo Therapeutics, Inc.10% OwnerLXEO
- MICROMET, INC.Director
- Morphic Holding, Inc.Director
- Nuvation Bio Inc.10% OwnerNUVB
- Omega Alpha SPACDirector, Chief Executive Officer, 10% Owner
- Paratek Pharmaceuticals, Inc.10% Owner
- Replimune Group, Inc.10% OwnerREPL
- Theseus Pharmaceuticals, Inc.Former 10% owner
- Translate Bio, Inc.10% Owner
Address
C/O IMAGENEBIO, INC. 12526 HIGH BLUFF DRIVE, SUITE 345
SAN DIEGO, CA, 92130